Author:
Magaña-Ortíz Denis,Fernández Francisco,Loske Achim M.,Gómez-Lim Miguel A.
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,General Medicine,Microbiology
Reference29 articles.
1. Alves-Silva MV, Nico D, Morrot A, Palatnik M, Palatnik-de-Sousa CB (2017) A chimera containing CD4+ and CD8+ T-cell epitopes of the Leishmania donovani nucleoside hydrolase (NH36) optimizes cross-protection against Leishmania amazonesis infection. Front Immunol 8:100
2. Bagirova M, Allahverdiyev AM, Abamor ES, Ullah I, Cosar G, Aydogdu M, Senturk H, Ergenoglu B (2016) Overview of dendritic cell-based vaccine development for leishmaniasis. Parasite Immunol 38:651–662
3. Coconi-Linares N, Ortega-Dávila E, López-González M, García-Machorro J, García-Cordero J, Steinman RM, Cedillo-Barrón L, Gómez-Lim MA (2013) Targeting of envelope domain III protein of DENV type 2 to DEC-205 receptor elicits neutralizing antibodies in mice. Vaccine 31:2366–2371
4. Conesa A, van den Hondel CA, Punt PJ (2000) Studies on the production of fungal peroxidases in Aspergillus niger. Appl Environ Microbiol 66:3016–3023
5. Duthie MS, Favila M, Hofmeyer KA, Tutterrow YL, Reed SJ, Laurance JD, Picone A, Guderian J, Bailor HR, Vallur AC, Liang H (2016) Strategic evaluation of vaccine candidate antigens for the prevention of visceral leishmaniasis. Vaccine 34:2779–2786
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献